Literature DB >> 9273859

Callosotomy for intractable epilepsy: overall outcome.

A Rougier1, B Claverie, J M Pedespan, C Marchal, P Loiseau.   

Abstract

The effectiveness of callosotomy to the control of medically intractable epilepsy is still discussed fifty years after the first reported cases. Nevertheless patient selection, type of seizures and epileptic syndromes are now better determined. Atonic and tonic astatic seizures characterized both by clinical and electroencephalographical specific patterns, are the most responsive. A favorable outcome, from > 50% reduction in seizure frequency to a complete cessation, is obtained from 60 to 80% of the patients. For tonic-clonic seizures, favorable outcome fluctuates from 40% to 80% principally according to the extension of the section. Other types of seizures are not indicated for callosotomy even though some improvement may be observed. Symptomatic secondary generalized epilepsy with predominent unilateral lesion and epileptic focus on bifrontal lobe epilepsy are the most suitable indication. True generalized epilepsies are associated with a less favorable outcome. Indeed, axial spasms, the most frequent type of drop attacks in the Lennox-Gastaut syndrome, probably do not have a cortical origin. Quality of life and social adjustment are assessed from a cohort of 20 cases of anterior two-third callosotomy. Actual benefits are in close connection with both seizure relief and age at operation. To obtain a gain in social independence not only seizure control has to be better but also surgery must be performed sooner.

Entities:  

Mesh:

Year:  1997        PMID: 9273859

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  9 in total

Review 1.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 2.  A risk-benefit assessment of therapies for Lennox-Gastaut syndrome.

Authors:  D Schmidt; B Bourgeois
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 3.  Treatment of Epileptic Encephalopathies: Current State of the Art.

Authors:  Hiroki Nariai; Susan Duberstein; Shlomo Shinnar
Journal:  J Child Neurol       Date:  2017-01-30       Impact factor: 1.987

4.  New treatment options for lennox-gastaut syndrome.

Authors:  Monica E Lemmon; Eric H Kossoff
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

5.  Outcome and long term follow-up after corpus callosotomy in childhood onset intractable epilepsy.

Authors:  Güzide Turanli; Dilek Yalnizoğlu; Demet Genç-Açikgöz; Nejat Akalan; Meral Topçu
Journal:  Childs Nerv Syst       Date:  2006-03-14       Impact factor: 1.475

6.  Postnatal lesion evidence against a primary role for the corpus callosum in mouse sociability.

Authors:  Mu Yang; Andrew M Clarke; Jacqueline N Crawley
Journal:  Eur J Neurosci       Date:  2009-04       Impact factor: 3.386

7.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

8.  Predictive value of electroencephalography for seizure outcome following corpus callosotomy in children.

Authors:  Go-Un Jeong; Hunmin Kim; Byung Chan Lim; Jong-Hee Chae; Ki Joong Kim; Yong Seung Hwang; Hee Hwang
Journal:  J Epilepsy Res       Date:  2011-12-30

Review 9.  Corpus Callosotomy for Controlling Epileptic Spasms: A Proposal for Surgical Selection.

Authors:  Tohru Okanishi; Ayataka Fujimoto
Journal:  Brain Sci       Date:  2021-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.